Indication
Febrile Neutropenia
10 clinical trials
20 products
Clinical trial
Study on Preference and Safety of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid MalignanciesStatus: Not yet recruiting, Estimated PCD: 2024-05-01
Product
HHPG-19KProduct
EC-18Clinical trial
EC-18 for Management of Chemotherapy-Induced Neutropenia in Patients With Advanced BC Receiving Low Febrile Neutropenia Risk Chemotherapy: Dose-Escalation, Open-label, Trial to Assess Safety and Tolerability of EC-18Status: Completed, Estimated PCD: 2019-11-26
Clinical trial
Early Neutropenic Fever De-escalation (END) of Antibiotics StudyStatus: Not yet recruiting, Estimated PCD: 2026-03-01
Product
Cessation of antibioticsClinical trial
Rational Use of Broad-spectrum Antibiotics as Empiric Antibiotic Therapy in Febrile Neutropenia in Recipients of Allogeneic Hematopoietic Cell TransplantationStatus: Recruiting, Estimated PCD: 2025-02-01
Product
Piperacillin-tazobactamProduct
cefepimeClinical trial
Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase (ESBL)-Producing Pathogens: a Randomized Double-blind Non-inferiority Trial.Status: Not yet recruiting, Estimated PCD: 2025-04-01
Product
Ceftolozane-TazobactamProduct
MeropenemClinical trial
Open-label, Randomized Comparative Study to Assess Biosimilar Pegfilgrastim Versus Biosimilar Filgrastim in Patients With Multiple Myeloma and Lymphoma Post Autologous Hematopoietic Stem Cell TransplantationStatus: Not yet recruiting, Estimated PCD: 2024-11-01
Product
Grastofil®Product
LapelgaClinical trial
Antimicrobial Revision in Patients With Persistent Febrile Neutropenia: A Prospective, Randomized TrialStatus: Recruiting, Estimated PCD: 2025-04-01
Product
MicafunginClinical trial
A Multicenter Randomized Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia in Hematological Patients: Efficacy and Microbiological SafetyStatus: Recruiting, Estimated PCD: 2024-03-14
Product
Fosfomycin CalciumClinical trial
Upwards Initial Adjustment of Wide-Spectrum Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Suspected Augmented Renal Clearance: A Randomized Controlled Trial With Therapeutic Drug MonitoringStatus: Not yet recruiting, Estimated PCD: 2026-03-01
Clinical trial
Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile NeutropeniaStatus: Recruiting, Estimated PCD: 2026-07-01
Product
Piperacillin + TazobactamProduct
CefepimeProduct
CeftazidimeProduct
VancomycinProduct
AmikacinProduct
CiprofloxacinProduct
Piperacillin and Tazobactam